Immunogenetics Lab in Santiago de Cuba: paradigm in the prevention of the perinatal hemolytic state

Authors

  • Ariel Arturo Matos Bayeau Banco Provincial de Sangre “Renato Guitart Rosell”, Santiago de Cuba
  • Rosa Castellanos Martínez Facultad de Ciencias Médicas No. 2, Universidad de Ciencias Médicas, Santiago de Cuba

Downloads

Download data is not yet available.

References

1. Kulinska R. Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis. Akush Ginekol (Sofiia). 2014; 53(2):58-63.

2. De Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sangunis. 2015; 109(2):99-113.

3. Mbalibulha Y, Muwanguzi E, Mugyenyi GR, Natukunda B. Occurrence of anti-D alloantibodies among pregnant women in Kasese District, Western Uganda. J Blood Med. 2015; 6: 125–9.

4. Altuntas N, Yenicesu I, Himmetoglu O, Kulali F, Kazanci E, Unal S, et al. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey. Transfus Apher Sci. 2013; 48(3): 377-80.

Downloads

Published

2017-06-09

How to Cite

1.
Matos Bayeau AA, Castellanos Martínez R. Immunogenetics Lab in Santiago de Cuba: paradigm in the prevention of the perinatal hemolytic state. MEDISAN [Internet]. 2017 Jun. 9 [cited 2025 Jun. 3];21(6). Available from: https://medisan.sld.cu/index.php/san/article/view/1123

Issue

Vol. 21 No. 6 (2017): MEDISAN

Section

Letters

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.